Literature DB >> 7982177

Dysplastic nevi as a melanoma risk factor in patients with familial melanoma.

W P Carey1, C J Thompson, M Synnestvedt, D Guerry, A Halpern, D Schultz, D E Elder.   

Abstract

BACKGROUND: Familial melanoma has been associated with "clinically atypical moles" or "dysplastic nevi," (DN) which are markers for increased melanoma risk. In addition, melanomas in these kindreds present at a younger age, and tend to be multiple.
METHODS: Melanoma incidence rates were determined for 710 members of 311 melanoma families, defined as kindreds in which melanoma had occurred in two or more blood relatives. Patients were classified either clinically or histologically as expressing DN. Melanomas that occurred before the first examination were recorded, and patients were followed prospectively for new melanomas.
RESULTS: In prospective follow-up, the age-adjusted melanoma incidence rate was 1710/100,000 patient-years in family members with DN. In contrast, the rate was zero (no melanomas occurred) in family members without DN. For family members with DN, but without a history of melanoma, the age-adjusted incidence rate of melanoma was 413/100,000 patient-years, whereas the rate was 2779/100,000 patient-years in family members with DN and a history of melanoma.
CONCLUSIONS: Dysplastic nevi and a history of melanoma are strong risk factors for subsequent melanoma. Prognostic factors are greatly improved for patients with melanomas diagnosed in follow-up compared with the first two melanomas in each kindred. These findings warrant surveillance of individuals with DN who are members of familial melanoma kindreds.

Entities:  

Mesh:

Year:  1994        PMID: 7982177     DOI: 10.1002/1097-0142(19941215)74:12<3118::aid-cncr2820741210>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.

Authors:  Jasper I van der Rhee; Femke A de Snoo; Hans F A Vasen; Wolter J Mooi; Hein Putter; Nelleke A Gruis; Nicole A Kukutsch; Wilma Bergman
Journal:  J Am Acad Dermatol       Date:  2011-05-12       Impact factor: 11.527

2.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

3.  Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.

Authors:  Rajmohan Murali; Chris Goumas; Anne Kricker; Lynn From; Klaus J Busam; Colin B Begg; Terence Dwyer; Stephen B Gruber; Peter A Kanetsky; Irene Orlow; Stefano Rosso; Nancy E Thomas; Marianne Berwick; Richard A Scolyer; Bruce K Armstrong
Journal:  Ann Surg Oncol       Date:  2011-09-13       Impact factor: 5.344

Review 4.  Molecular aspects of melanocytic dysplastic nevi.

Authors:  Mahmoud Rezk Abd-Elwahed Hussein; Gary Stewart Wood
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

5.  Histologic features of melanoma associated with CDKN2A genotype.

Authors:  Michael R Sargen; Peter A Kanetsky; Julia Newton-Bishop; Nicholas K Hayward; Graham J Mann; Nelleke A Gruis; Margaret A Tucker; Alisa M Goldstein; Giovanna Bianchi-Scarra; Susana Puig; David E Elder
Journal:  J Am Acad Dermatol       Date:  2015-01-13       Impact factor: 11.527

Review 6.  Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.

Authors:  M R Hussein
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

7.  Telomerase activity in melanocytic lesions: A potential marker of tumor biology.

Authors:  P Rudolph; C Schubert; S Tamm; K Heidorn; A Hauschild; I Michalska; S Majewski; G Krupp; S Jablonska; R Parwaresch
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 8.  Selection criteria for genetic assessment of patients with familial melanoma.

Authors:  Sancy A Leachman; John Carucci; Wendy Kohlmann; Kimberly C Banks; Maryam M Asgari; Wilma Bergman; Giovanna Bianchi-Scarrà; Teresa Brentnall; Brigitte Bressac-de Paillerets; William Bruno; Clara Curiel-Lewandrowski; Femke A de Snoo; Tadeusz Debniak; Marie-France Demierre; David Elder; Alisa M Goldstein; Jane Grant-Kels; Allan C Halpern; Christian Ingvar; Richard F Kefford; Julie Lang; Rona M MacKie; Graham J Mann; Kurt Mueller; Julia Newton-Bishop; Håkan Olsson; Gloria M Petersen; Susana Puig; Darrell Rigel; Susan M Swetter; Margaret A Tucker; Emanuel Yakobson; John A Zitelli; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2009-10       Impact factor: 11.527

Review 9.  Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article.

Authors:  Juliana Hypólito Silva; B C de Sá; Alexandre Leon Ribeiro de Avila; Gilles Landman; João Pedreira Duprat Neto
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 10.  Pulmonary metastatic melanoma: current state of diagnostic imaging and treatments.

Authors:  Kermit S Zhang; Tomer Pelleg; Sabrina Campbell; Catalina Rubio; Anthony Lukas Loschner; Susanti Ie
Journal:  Melanoma Manag       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.